Receipt of chemotherapy among medicare patients with cancer by type of supplemental insurance

Journal of Clinical Oncology

Volumn 33, Issue 4, 2015, Pages 312-318

  Warren, Joan L ^a   Butler, Eboné N ^c   Stevens, Jennifer ^b   Lathan, Christopher S ^d   Noone, Anne Michelle ^a   Ward, Kevin C ^e   Harlan, Linda C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CHARLSON COMORBIDITY INDEX; COLORECTAL CANCER; CONSULTATION; FEMALE; HEALTH CARE ACCESS; HEALTH INSURANCE; HEALTH INSURANCE ELIGIBILITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; NON SMALL CELL LUNG CANCER; OBSERVATIONAL STUDY; ONCOLOGIST; OVARY CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VERY ELDERLY; ANIMAL; ECONOMICS; HEALTH CARE COST; INSURANCE; MULTIVARIATE ANALYSIS; NEOPLASMS; PATIENT REFERRAL; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; AGED, 80 AND OVER; ANIMALS; FEMALE; HEALTH EXPENDITURES; HUMANS; INSURANCE COVERAGE; LOGISTIC MODELS; MALE; MEDICAID; MEDICARE; MEDICARE PART B; MULTIVARIATE ANALYSIS; NEOPLASMS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES;

EID: 84921920069     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.3107     Document Type: Article

References (27)

1. Riley GF: Trends in out-of-pocket healthcare costs among older community-dwelling Medicare beneficiaries. Am J Manag Care 14:692-696, 2008
2. Warren JL, Yabroff KR, Meekins A, et al: Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst 100:888-897, 2008
3. Davidoff AJ, Erten M, Shaffer T, et al: Out-ofpocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer 119:1257-1265, 2013
4. Jacobson G, Neuman T, Damico A: Medicare's Role for Dual Eligible Beneficiaries. http:// kff.org/medicaid/slide/dually-eligible-beneficiaries-comprise-20-of-the-medicare-population-and-15-of-the-medicaid-population-2008/
5. Harlan LC, Greene AL, Clegg LX, et al: Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol 23: 9079-9088, 2005
6. Warren JL, Harlan LC, Stevens J, et al: Multiple myeloma treatment transformed: A populationbased study of changes in initial management approaches in the United States. J Clin Oncol 31: 1984-1989, 2013
7. Bradley CJ, Dahman B, Given CW: Inadequate access to surgeons: Reason for disparate cancer care? Med 47:758-764, 2009
8. Davidoff AJ, Shaffer T, Erten MZ, et al: Use and spending on antineoplastic therapy for Medicare beneficiaries with cancer. Med Care 51:351-360, 2013
9. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology: Colon Cancer (version 2. 2005).
10. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer (version 1. 2005).
11. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology: Ovarian Cancer (version 1. 2002).
12. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology: Rectal Cancer (version 3. 2005).
13. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology: Breast Cancer (version 1. 2005).
14. National Cancer Institute: Applied Research Cancer Control and Population Sciences: Patterns of Care/Quality of Care Studies. http://healthservices .cancer.gov/surveys/poc/
15. Warren JL, Klabunde CN, Schrag D, et al: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40:IV3-IV18, 2002 (suppl)
16. Graubard BI, Korn EL: Predictive margins with survey data. Biometrics 55:652-659, 1999
17. Koroukian SM, Xu F, Murray P: Ability of Medicare claims data to identify nursing home patients: A validation study. Med Care 46:1184-1187, 2008
18. Jackson Healthcare: A Tough Time for Physicians: 2012 Medical Practice and Attitude Report. http://www.jacksonhealthcare.com/media/ 137811/physiciantrendsreport-ebook0712-final .pdf
19. Erikson C, Salsberg E, Forte G, et al: Future supply and demand for oncologists: Challenges to assuring access to oncology services. J Oncol Pract 3:79-86, 2007
20. Centers for Medicare and Medicaid Services: Qs & As on the Increased Medicaid Payment for Primary Care. http://www.medicaid.gov/ affordablecareact/provisions/downloads/qanda-set-ii-increased-payments-for-pcps.pdf
21. Washington University Center for Health Policy: Health Care Access for Medicaid Patients: Physicians and Dentists Interview Study. http://healthpolicy.wustl .edu/Content/HealthCareAccess.html?OpenDocument
22. Richardson LC, Tian L, Voti L, et al: The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regionalstage breast cancer in Florida. Am J Public Health 96:160-166, 2006
23. Liu JH, Zingmond DS, McGory ML, et al: Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 296:1973-1980, 2006
24. Raborn ML, Pelletier EM, Smith DB, et al: Patient out-of-pocket payments for oral oncolytics: Results from a 2009 US claims data analysis. Am J Manag Care 18:SP57-SP64, 2012
25. Ward MM, Ullrich F, Matthews K, et al: Who does not receive treatment for cancer? J Oncol Pract 9:20-26, 2013
26. Kaiser Family Foundation: Medigap: Spotlight on Enrollment, Premiums, and Recent Trends. http:// kaiserfamilyfoundation.files.wordpress.com/2013/04/ 8412-2.pdf
27. Koroukian SM, Dahman B, Copeland G, et al: The utility of the state buy-in variable in the Medicare denominator file to identify dually eligible Medicare-Medicaid beneficiaries: A validation study. Health Serv Res 45:265-282, 2010